121 related articles for article (PubMed ID: 2568935)
1. Characterization of the beta 1-adrenoceptor stimulatory effects of the partial beta 1-agonists acebutolol, xamoterol, H142/08 and H201/70.
Abrahamsson T
Eur J Pharmacol; 1989 May; 164(1):121-8. PubMed ID: 2568935
[TBL] [Abstract][Full Text] [Related]
2. The beta 1- and beta 2-adrenoceptor stimulatory effects of alprenolol, oxprenolol and pindolol: a study in the isolated right atrium and uterus of the rat.
Abrahamsson T
Br J Pharmacol; 1986 Apr; 87(4):657-64. PubMed ID: 2871880
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
4. The in vitro pharmacology of xamoterol (ICI 118,587).
Malta E; Mian MA; Raper C
Br J Pharmacol; 1985 May; 85(1):179-87. PubMed ID: 2862938
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of beta-adrenoceptor partial agonists on isolated rat atrium.
Vigholt-Sørensen E; Påby L; Halliday SE; Snow HM
Pharmacol Toxicol; 1991 Nov; 69(5):351-4. PubMed ID: 1687080
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
Hattori Y; Sakuma I; Nakao Y; Kanno M
J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
[TBL] [Abstract][Full Text] [Related]
7. Selective and full beta 1-adrenoceptor agonist action of a catechol derivative of denopamine (T-0509) in the guinea-pig cardiac muscle and trachea: comparison with denopamine, xamoterol and isoprenaline.
Yabana H; Watanabe H; Narita H; Nagao T
Br J Pharmacol; 1992 Jun; 106(2):335-41. PubMed ID: 1356559
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of xamoterol and isoprenaline on rat cardiac beta-adrenoceptors: studies of function and regulation.
Kowalski MT; Haworth D; Lu X; Thomson DS; Barnett DB
Br J Pharmacol; 1990 Jan; 99(1):27-30. PubMed ID: 2158836
[TBL] [Abstract][Full Text] [Related]
9. Single and combined myocardial pharmacodynamics of xamoterol, isoprenaline and g-strophanthin in the isolated rabbit heart.
Vigholt Sørensen E; Nielsen-Kudsk F
Eur J Pharmacol; 1986 Jun; 125(3):363-71. PubMed ID: 2874040
[TBL] [Abstract][Full Text] [Related]
10. beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells.
Haynes JM
Eur J Pharmacol; 2007 Sep; 570(1-3):18-26. PubMed ID: 17617401
[TBL] [Abstract][Full Text] [Related]
11. Cardiac beta-adrenoceptor regulation and the effects of partial agonism.
Barnett DB; Lu XY
Am J Cardiol; 1991 May; 67(12):18C-19C. PubMed ID: 1673585
[TBL] [Abstract][Full Text] [Related]
12. Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat.
Kaumann AJ; Molenaar P
Br J Pharmacol; 1996 Aug; 118(8):2085-98. PubMed ID: 8864547
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular actions of xamoterol (ICI 118,587) in anaesthetized cats, rats, and guinea pigs.
Mian MA; Malta E; Raper C
J Cardiovasc Pharmacol; 1986; 8(2):314-23. PubMed ID: 2422470
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo characterization of intrinsic sympathomimetic activity in normal and heart failure rats.
Willette RN; Aiyar N; Yue TL; Mitchell MP; Disa J; Storer BL; Naselsky DP; Stadel JM; Ohlstein EH; Ruffolo RR
J Pharmacol Exp Ther; 1999 Apr; 289(1):48-53. PubMed ID: 10086986
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the beta adrenoceptor subtype(s) mediating the positive inotropic effects of epinine, dopamine, dobutamine, denopamine and xamoterol in isolated human right atrium.
Deighton NM; Motomura S; Bals S; Zerkowski HR; Brodde OE
J Pharmacol Exp Ther; 1992 Aug; 262(2):532-8. PubMed ID: 1354251
[TBL] [Abstract][Full Text] [Related]
16. Effects of xamoterol on the reversible cycling of cardiac beta-adrenoceptors.
Limas CJ; Limas C
J Cardiovasc Pharmacol; 1990 Dec; 16(6):945-51. PubMed ID: 1704988
[TBL] [Abstract][Full Text] [Related]
17. In vitro effects of beta adrenoceptor agonists and antagonists on the rat ovarian suspensory ligament.
Stanton HC; Dungan KW
J Pharmacol Exp Ther; 1986 Nov; 239(2):591-6. PubMed ID: 2877087
[TBL] [Abstract][Full Text] [Related]
18. Partial agonist activity of bucindolol is dependent on the activation state of the human beta1-adrenergic receptor.
Maack C; Böhm M; Vlaskin L; Dabew E; Lorenz K; Schäfers HJ; Lohse MJ; Engelhardt S
Circulation; 2003 Jul; 108(3):348-53. PubMed ID: 12847069
[TBL] [Abstract][Full Text] [Related]
19. Beta 1- and beta 2-adrenoceptor affinity and stimulatory effects of (S)-pindolol and iodinated (S)-pindolol.
Abrahamsson T; Nerme V
Pharmacol Toxicol; 1987 Feb; 60(2):120-4. PubMed ID: 2883645
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of the receptors involved in the beta-adrenoceptor-mediated stimulation of the L-type Ca2+ current in frog ventricular myocytes.
Skeberdis VA; Jurevicius J; Fischmeister R
Br J Pharmacol; 1997 Aug; 121(7):1277-86. PubMed ID: 9257904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
